Fund+ is a venture capital firm primarily focused on investing in life sciences, particularly therapeutics, at advanced development stages in Europe, with a strong emphasis on Belgium. The firm aims to become a significant minority shareholder (over 10%) in its portfolio companies, with individual investments typically ranging from EUR 5 million to EUR 15 million, and plays an active role as a board member.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (67% of deals). Average disclosed round size is $126.7M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$200M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Tubulis | Series C | $308M | Oct 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
 TargED Biopharmaceuticals | Series A | $39M | Feb 2022 |
Top Co-Investors
Andera Partners2 shared
Bpifrance1 shared
Invus1 shared
UI Investissement1 shared
Kurma Partners1 shared
Omnes Capital1 shared
Wellington Management1 shared
Nextech Invest1 shared
EQT Life Sciences1 shared
Frazier Life Sciences1 shared
Deep Track Capital1 shared
Bayern Kapital1 shared
Seventure Partners1 shared
HTGF1 shared
Hadean Ventures1 shared
INKEF Capital1 shared
Sunstone Life Science Ventures1 shared
Last updated: 7 April 2026